For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Testosterone - Low sexual desire in menopausal women
PAD Profile : Testosterone - Low sexual desire in menopausal women
Traffic Light Status
Status 1 of 2.
- Cream
To support the safe use of testosterone in menopause please note the 'BMS Statement on Testosterone'
Status 2 of 2.
- Gel
To support the safe use of testosterone in menopause please note the 'BMS Statement on Testosterone'
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
To support the safe use of testosterone in menopause please note the 'BMS Statement on Testosterone'
The Surrey Heartlands Integrated Health System Area Prescribing Committee (APC) has agreed that topical testosterone should be prescribed generically, ideally using Drug Tariff descriptions.
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approved a change in traffic light status from BLUE to GREEN for testosterone gel.
The following testosterone products are NON-FORMULARY as they are either unlicensed in the UK or not available in biologically appropriate doses for the indication: Androfeme, Testogel, Testavan
Please note; Testim has been discontinued.
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed that treatment of low sexual desire in menopausal women with testosterone 1% cream will be given a NON-FORMULARY traffic light status.
Androfeme 1% cream is unlicensed in the UK and there are licensed testosterone preparations available that are being used off-label.